RAYMOND JAMES & ASSOCIATES - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 90 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,940
+80.1%
30,0000.0%0.00%
Q2 2023$4,965
-83.0%
30,0000.0%0.00%
Q1 2023$29,280
-6.2%
30,0000.0%0.00%
Q4 2022$31,200
+35.7%
30,000
+50.0%
0.00%
Q3 2022$23,000
-37.8%
20,0000.0%0.00%
Q2 2022$37,000
-39.3%
20,0000.0%0.00%
Q1 2022$61,000
-22.8%
20,000
-4.8%
0.00%
Q4 2021$79,000
-23.3%
21,000
+5.0%
0.00%
Q3 2021$103,000
+22.6%
20,000
-9.1%
0.00%
Q2 2021$84,000
+47.4%
22,0000.0%0.00%
Q1 2021$57,000
+3.6%
22,0000.0%0.00%
Q4 2020$55,000
+19.6%
22,0000.0%0.00%
Q3 2020$46,000
-41.0%
22,000
-12.0%
0.00%
Q2 2020$78,000
-51.9%
25,000
-64.7%
0.00%
Q1 2020$162,000
-34.4%
70,900
+3.8%
0.00%
Q4 2019$247,000
+6.0%
68,3000.0%0.00%
Q3 2019$233,000
-21.8%
68,300
+7.9%
0.00%
Q2 2019$298,000
+30.1%
63,300
-7.3%
0.00%
Q1 2019$229,000
+27.9%
68,300
+1.5%
0.00%
Q4 2018$179,000
-51.1%
67,300
+3.1%
0.00%
-100.0%
Q3 2018$366,000
+125.9%
65,300
+104.1%
0.00%
Q2 2018$162,000
-28.3%
32,000
-3.3%
0.00%
Q1 2018$226,000
+65.0%
33,080
+81.8%
0.00%
Q4 2017$137,000
+18.1%
18,200
-9.9%
0.00%
Q3 2017$116,000
+52.6%
20,200
+34.7%
0.00%
Q2 2017$76,000
+94.9%
15,0000.0%0.00%
Q1 2017$39,000
-29.1%
15,000
-50.0%
0.00%
Q3 2016$55,00030,0000.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders